The combined company will clinically advance Epsilogen's MOv18 IgE antibody in ovarian cancer and TigaTx's anti-EGFR IgA antibody.

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer ...

UK biotech Epsilogen has bought US-based TigaTx, pooling their resources to create what it says will be a leader in 'pan-isotope' cancer antibodies. Epsilogen rose to prominence a few years ago by ...

High-speed atomic force m (HS-AFM) reveals nanoscale differences in small extracellular vesicles (sEVs), improving biomarker ...

Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, today announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company ...

Antiphospholipid Antibody Syndrome APS is an autoimmune condition where the immune system of the body mistakenly forms antibodies that target healthy tissues Scroll down to learn how this condition af ...